Q & A: Introducing Biologics with Dr. Paul Yamauchi

In March, the FDA approved Dupixent, the first biologic medication for adults with moderate to severe atopic dermatitis. Clinical research investigator Dr Paul Yamauchi answers questions about the new medication.